Deal snapshot: SK Capital Acquires Majority Stake in French Pharmaceuticals Provider SEQENS.

MANews-(C)2009-2021

Funds advised by Florida-based investment firm SK Capital Partners has acquired a majority shareholding in French pharmaceutical solutions and speciality ingredients companies SEQENS, to strengthen position in global pharmaceutical solutions and speciality ingredients markets, the company said.

Terms of the transaction were not disclosed. SK Capital is investing...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT